You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

32 search results for: disease modification

The Impact of Advanced Systemic Therapies on <b>Disease</b> Control and Potential Remission in Atopic Dermatitis

expert video

The Impact of Advanced Systemic Therapies on Disease Control and Potential Remission in Atopic Dermatitis

10 min

Dermatology

Exploring the concept of disease modification relating to therapeutic interventions with targeted systemic therapies in atopic dermatitis.

Early Intervention and <b>Disease</b> <b>Modification</b> in AD: Can We Change the Course of the <b>Disease</b>?

expert video

Early Intervention and Disease Modification in AD: Can We Change the Course of the Disease?

45 min

Dermatology

This video presentation of the September 2024 ADVENT symposium at EADV’s Annual Meeting in Amsterdam, the Netherlands features Dr. Stephan Weidinger, Dr. Eric Simpson, and Dr. Marjolein de Bruin-Weller. The faculty investigate the inflammatory processes driven by type 2 cytokines that lead to the local and systemic clinical effects of AD, the potential benefits of treating patients with AD early in the disease course, and the emerging real-world data on the use of advanced systemic therapies for patients with AD.

expert video

Can Early Intervention Shape the Course of Atopic Dermatitis?

15 min

Dermatology

Exploring the concept of disease modification through early intervention with targeted systemic therapies in atopic dermatitis.

Podcast

ADVENT On Air | Expert Discussions in Dermatology

45 min

Dermatology

Listen to the latest updates in type 2 inflammatory science and associated skin diseases, brought to you by leading dermatology experts in the field. ADVENT On Air podcasts feature scientific conversations that explore new research into the pathophysiology, clinical features, and disease burden for a range of dermatological diseases linked to type 2 inflammation, including atopic dermatitis (AD) and prurigo nodularis (PN). Hear new insights revealed through expert-led conversations below or in your preferred podcast app.

Impact of Advanced Systemic Therapies on <b>Disease</b> Control in AD

expert video

Impact of Advanced Systemic Therapies on Disease Control in AD

6 min

Dermatology

Dr. Simpson discusses impact of advanced systemic therapies in AD, and the link between inhibition of type 2 inflammation and reduced IgE levels.

Atopic Dermatitis (AD) in Children: Early Intervention Can Reduce Long-Term <b>Disease</b> Impact

expert video

Atopic Dermatitis (AD) in Children: Early Intervention Can Reduce Long-Term Disease Impact

69 min

Dermatology

Highlights from the 2023 World Congress of Dermatology ADVENT symposium, exploring intervention considerations for children with atopic dermatitis.

expert video

Evolving Topics in Type 2 Inflammation

49 min

Type 2 Inflammation

Drs. Eric Simpson, Jonathan Spergel, and Profs. Francesca Puggioni, Ian Pavord, Peter Hellings discuss emerging topics in type 2 inflammatory diseases

expert video

What Could Remission Mean in AD?

1 min

Dermatology

Dr. Simpson explores the concept of remission in AD, focusing on minimal disease activity and long-term remission, discussing how disease modification in AD can impact the course of the disease and its associated comorbidities.

expert video

Type 2 Inflammation Alters the Structure and Function of the Skin in Atopic Dermatitis Interview

5 min

Dermatology

Exclusive interview with Prof. Lisa A. Beck delving into the potential for disease modification and the role of the microbiome in atopic dermatitis.

expert video

Challenges Faced by Dermatologists When Managing Atopic Dermatitis in Children

13 min

Dermatology

Explore WCD 2023 ADVENT symposium's insights into managing short and long-term challenges of pediatric atopic dermatitis.

expert video

Challenges Faced by Dermatologists When Managing Atopic Dermatitis in Children - Expert Interview

8 min

Dermatology

Watch ADVENT now: Dermatologist Mark Koh describes the Challenges Faced by Dermatologists When Managing Atopic Dermatitis in Children.

expert video

Emerging Clinical Data in Children With Atopic Dermatitis- Q&As

6 min

Dermatology

Explore the WCD 2023 ADVENT symposium’s insights into current and emerging treatment strategies for managing pediatric atopic dermatitis.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: DenmarkChange country/region